Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex

British Journal of Pharmacology

Volumn 160, Issue 3, 2010, Pages 736-746

  Ho, W Sv ^a,c   Patel, S ^a,b   Thompson, J R ^a   Roberts, C J ^a   Stuhr, K L ^a   Hillard, C J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

2 arachidonoylglycerol; Anandamide; Endocannabinoid; Hyperaemic response; Laser Doppler flowmetry; Rimonabant; Whisker barrel cortex

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BICUCULLINE; CANNABINOID 1 RECEPTOR; PROTEIN C FOS; RIMONABANT; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; BENZOXAZINE DERIVATIVE; CANNABINOID RECEPTOR AFFECTING AGENT; ENDOCANNABINOID; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; EVOKED SOMATOSENSORY RESPONSE; HEMISPHERIC DOMINANCE; HYPEREMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LOCOMOTION; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; STIMULUS RESPONSE; VIBRISSA; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ARACHIDONIC ACIDS; BENZOXAZINES; BICUCULLINE; CANNABINOID RECEPTOR MODULATORS; ENDOCANNABINOIDS; FUNCTIONAL LATERALITY; GLYCERIDES; HYPEREMIA; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SOMATOSENSORY CORTEX; VIBRISSAE;

EID: 77952633980     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00772.x     Document Type: Article

References (56)

1. Alexander SPH, Mathie A, Peters JA (2009). Guide to receptors and channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
2. Bender VA, Bender KJ, Brasier DJ, Feldman DE (2006). Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J Neurosci 26 : 4166 4177.
3. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N et al. (2005). Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25 : 6845 6856.
4. Bonvento G, Sibson N, Pellerin L (2002). Does glutamate image your thoughts? Trends Neurosci 25 : 359 364.
5. Cheer JF, Wassum KM, Wightman RM (2006). Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats. J Neurochem 97 : 1145 1154.
6. Connors BW, Gutnick MJ (1990). Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci 13 : 99 104.
7. D'Amico M, Cannizzaro C, Preziosi P, Martire M (2004). Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]d-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus. Neurochem Res 29 : 1553 1561.
8. Deshmukh S, Onozuka K, Bender KJ, Bender VA, Lutz B, Mackie K et al. (2007). Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. Neuroscience 145 : 279 287.
9. Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU et al. (2006). Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 26 : 5794 5799.
10. D'Souza DC (2007). Cannabinoids and psychosis. Int Rev Neurobiol 78 : 289 326.
11. Edwards CR, Skosnik PD, Steinmetz AB, O'Donnell BF, Hetrick WP (2009). Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations. Behav Neurosci 123 : 894 904.
12. Eggan SM, Lewis DA (2007). Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 17 : 175 191.
13. Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA (1992). Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42 : 838 845.
14. Fortin DA, Levine ES (2007). Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb Cortex 17 : 163 174.
15. Fortin DA, Trettel J, Levine ES (2004). Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92 : 2105 2212.
16. Freedman R, Olincy A, Ross RG, Waldo MC, Stevens KE, Adler LE et al. (2003). The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep 5 : 155 161.
17. Freund TF, Katona I, Piomelli D (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83 : 1017 1066.
18. 2+ channel current. Am J Physiol 276 : H2085 H2093.
19. Glass M, Dragunow M, Faull RL (1997). Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77 : 299 318.
20. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I et al. (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12 : 3239 3249.
21. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11 : 563 583.
22. Hill EL, Gallopin T, Ferezou I, Cauli B, Rossier J, Schweitzer P et al. (2007). Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol 97 : 2580 2589.
23. Hoffman AF, Lupica CR (2000). Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. Eur J Pharmacol 391 : 269 274.
24. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K et al. (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19 : 4544 4558.
25. Kawaguchi Y, Kubota Y (1997). GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 7 : 476 486.
26. Kreitzer AC, Regehr WG (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29 : 717 727.
27. Larkum ME, Zhu JJ, Sakmann B (1999). A new cellular mechanism for coupling inputs arriving at different cortical layers. Nature 398 : 338 341.
28. Li L, Bender KJ, Drew PJ, Jadhav SP, Sylwestrak E, Feldman DE (2009). Endocannabinoid signaling is required for development and critical period plasticity of the whisker map in somatosensory cortex. Neuron 64 : 537 549.
29. Liu CH, Heynen AJ, Shuler MG, Bear MF (2008). Cannabinoid receptor blockade reveals parallel plasticity mechanisms in different layers of mouse visual cortex. Neuron 58 : 340 345.
30. Maccarrone M, Fiori A, Bari M, Granata F, Gasperi V, De Stefano ME et al. (2006). Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells. Thromb Haemost 95 : 117 127.
31. McCasland JS, Hibbard LS (1997). GABAergic neurons in barrel cortex show strong, whisker-dependent metabolic activation during normal behavior. J Neurosci 17 : 5509 5527.
32. MacLennan S, Reynen P, Kwan J, Bonhaus D (1998). Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br J Pharmacol 124 : 619 622.
33. Marsicano G, Lutz B (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11 : 4213 4225.
34. Morgan JI, Curran T (1988). Calcium as a modulator of the immediate-early gene cascade in neurons. Cell Calcium 9 : 303 311.
35. Morgan JI, Cohen DR, Hempstead JL, Curran T (1987). Mapping patterns of c-Fos expression in the central nervous system after seizure. Science 237 : 192 197.
36. Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E (2000). Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol 361 : 19 24.
37. New DC, Wong YH (2003). BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS Lett 536 : 157 160.
38. Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF et al. (2009). Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl) piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther 331 : 591 597.
39. Patel S, Hillard CJ (2003). Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Res 963 : 15 25.
40. Patel S, Gerrits R, Muthian S, Greene AS, Hillard CJ (2002). The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. Neurosci Lett 335 : 95 98.
41. Patel S, Carrier EJ, Ho WS, Rademacher DJ, Cunningham S, Reddy DS et al. (2005). The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J Lipid Res 46 : 342 349.
42. Pitler TA, Alger BE (1992). Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12 : 4122 4132.
43. Pontzer NJ, Wilkison DM (1987). Inhibition of heterosensory thalamocortical evoked potentials by delta-9-tetrahydrocannabinol. Exp Neurol 97 : 644 652.
44. Pontzer NJ, Hosko MJ, Wilkison DM (1986). Alteration of electrical correlates of sensory processing by tetrahydrocannabinol. Exp Neurol 91 : 127 135.
45. Rademacher DJ, Patel S, Ho WS, Savoie AM, Rusch NJ, Gauthier KM et al. (2005). U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance. Am J Physiol Heart Circ Physiol 288 : H2694 H2701.
46. Raichle ME (1998). Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci USA 95 : 765 772.
47. Rodriguez JJ, Mackie K, Pickel VM (2001). Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci 21 : 823 833.
48. Sanchez C, Galve-Roperh I, Canova C, Brachet P, Guzman M (1998). Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett 436 : 6 10.
49. Simons DJ (1978). Response properties of vibrissa units in rat SI somatosensory neocortex. J Neurophysiol 41 : 798 820.
50. Slipetz DM, O'Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y et al. (1995). Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol 48 : 352 361.
51. Soltesz I, Smetters DK, Mody I (1995). Tonic inhibition originates from synapses close to the soma. Neuron 14 : 1273 1283.
52. Trettel J, Levine ES (2002). Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J Neurophysiol 88 : 534 539.
53. Trettel J, Levine ES (2003). Endocannabinoids mediate rapid retrograde signaling at interneuron - >pyramidal neuron synapses of the neocortex. J Neurophysiol 89 : 2334 2338.
54. Trettel J, Fortin DA, Levine ES (2004). Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 556 : 95 107.
55. Wagner JA, Jarai Z, Batkai S, Kunos G (2001). Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur J Pharmacol 423 : 203 210.
56. Wilkison DM, Pontzer N, Hosko MJ (1982). Slowing of cortical somatosensory evoked activity by delta 9-tetrahydrocannabinol and dimethylheptylpyran in alpha-chloralose-anesthetized cats. Neuropharmacology 21 : 705 709.